Shilajit for Women: Research, Special Considerations, Safety
In short: The vast majority of shilajit studies were conducted with men. For women, the most interesting research is a placebo-controlled investigation in postmenopausal women, in which bone density readings were collected over 48 weeks. No authorised health claims exist for shilajit in the EU, and during pregnancy and breastfeeding we advise against taking it as a matter of principle. This article puts the data into sober perspective.
Important: No health claims are authorised for shilajit/mumijo in the EU (Regulation (EC) No 1924/2006). This article reports neutrally on the state of research and makes no claims of effect.
Why the data on women is particularly thin
Anyone who goes through the shilajit research quickly notices: the best-known human studies, such as those measuring testosterone or sperm parameters, were conducted exclusively with male participants. Results from these studies cannot be transferred to women. At the same time, women's interest in the mountain resin is growing noticeably, driven by social media. For an overview of the research as a whole, see our articles Shilajit Effects: What Do Studies Really Say? and Shilajit Studies at a Glance.
The bone density study in postmenopausal women
The currently most relevant investigation with female participants dates from 2022. Here are the key facts, purely as reported:
| Study design | randomised, double-blind, placebo-controlled |
|---|---|
| Participants | around 60 postmenopausal women with reduced bone density (osteopenia) |
| Dosage | 250 mg or 500 mg standardised shilajit daily, in two groups |
| Duration | 48 weeks |
| Measured values | bone density parameters and laboratory markers |
| Result | At the end of the study, more favourable readings were documented in the shilajit groups than under placebo (Pingali & Nutalapati, 2022, Phytomedicine) |
This study, too, has clear limits: it is a single investigation from a single centre with a small sample, conducted in women with osteopenia, that is, not in healthy women. Surrogate parameters were measured, not everyday endpoints. Independent replication is lacking. The data is not sufficient for authorised health claims.
Minerals: what can be said in a legally clean way
Shilajit resin naturally contains minerals and trace elements. For some of these nutrients, not for shilajit itself, authorised claims exist in the EU. Based on a daily dose of 0.9 g of Vitadote® Shilajit Resin:
- Calcium (72% NRV): Calcium is needed for the maintenance of normal bones.
- Magnesium (108% NRV): Magnesium contributes to a reduction of tiredness and fatigue.
- Iron (31% NRV): Iron contributes to normal oxygen transport in the body.
These statements refer exclusively to the respective minerals. A varied, balanced diet and a healthy lifestyle are important; food supplements do not replace them.
Safety: what women should know before taking it
More important than any discussion of studies are the practical safety points:
- Pregnancy and breastfeeding: Here we clearly advise against taking it; safety data is lacking. Explained in detail in our article Shilajit During Pregnancy & Breastfeeding.
- Natural iron content: If you take iron supplements or have an iron storage disorder (haemochromatosis), talk to your doctor before use.
- Medication: If you take medication regularly, such as thyroid hormones, the question belongs in your doctor's consultation.
- Quality: Unpurified or untested resin can contain heavy metals. Look for a certificate of analysis per batch; what it should contain is explained under Lab Tests & Quality.
- Tolerability: Possible initial reactions such as gastrointestinal complaints are described in our article on shilajit side effects.
Social media trends viewed soberly
On social media, many things are attributed to shilajit in connection with women, from skin and hair to cycle and hormones. Across the board, the following applies: there are neither authorised claims nor robust human studies with these endpoints. The only larger investigation in women is the bone density study described above. In this category, you can recognise reputable information by the fact that it names this gap openly instead of filling it with promises.
Taking it in practice
The same basic rules apply to women as to all adults: the recommended intake of the product in question is decisive, the stated daily amount must not be exceeded, and starting with a smaller amount has proven itself in practice. Whether resin or tablets fit your routine better is a matter of taste and habit. You will find a complete guide in our article on how to take shilajit.
View lab-tested shilajit: Vitadote® Shilajit Resin 30g (76–83% fulvic acid, COA per batch) or Vitadote® Shilajit Tablets 120×200mg, taste-neutral and precisely dosed, with published analysis values per batch.
Frequently asked questions (FAQ)
Is shilajit suitable for women?
Shilajit is a food supplement for healthy adults, regardless of gender. During pregnancy and breastfeeding we advise against taking it; in case of illness or medication use, the decision belongs in a medical consultation.
Are there shilajit studies with women?
Yes, but few. The most important is a placebo-controlled 48-week study with around 60 postmenopausal women, in which bone density readings were collected. A single study does not amount to robust evidence.
Does the dosage differ for women?
There is no scientifically established, gender-specific dosage. The recommended intake of the product is decisive; it applies to adults in general.
May pregnant or breastfeeding women take shilajit?
We advise against it. Safety data for these life stages is lacking; our dedicated article explains the background in detail.
What should women taking iron supplements bear in mind?
Shilajit naturally contains iron. If you already supplement iron or have an iron storage disorder, clarify the combined intake with your doctor beforehand.
Sources & further reading
- Pingali & Nutalapati (2022): Shilajit extract dose-dependently preserves bone mineral density in postmenopausal women with osteopenia. Phytomedicine. PubMed search
- Pandit et al. (2016): Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. PubMed search
- Stohs (2014): Safety and efficacy of shilajit (mumie, moomiyo). Phytotherapy Research. PubMed search
- EU Register on Nutrition and Health Claims (European Commission). ec.europa.eu
This article is for neutral information purposes and does not replace medical advice. Food supplements are no substitute for a balanced, varied diet and a healthy lifestyle. If you have a medical condition, take medication, are pregnant or breastfeeding, talk to your doctor or pharmacist before use.
Redaktion shilajitkaufen.com – We write to a fixed editorial standard: studies reported neutrally, no healing claims, sources under every article. More about our quality criteria: Lab Tests & Quality.